United States Interventional Cardiology Market Outlook to 2025

  • ID: 4518952
  • Report
  • Region: United States
  • 152 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asahi Kasei Corp
  • Boston Scientific Corp
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic Plc
  • MORE
United States Interventional Cardiology Market Outlook to 2025

Summary

The new report, United States Interventional Cardiology Market Outlook to 2025, provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Interventional Cardiology market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Interventional Cardiology market.
  • Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market.
  • Key players covered include Abbott Laboratories, Boston Scientific Corp, Medtronic plc, and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asahi Kasei Corp
  • Boston Scientific Corp
  • Cardinal Health Inc
  • Cook Medical Inc
  • Medtronic Plc
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Interventional Cardiology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Interventional Cardiology Market, United States
3.1 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025
3.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.5 PTCA Balloons Catheters Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Interventional Cardiology Market, United States, Volume (Units), 2015-2025
3.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025
3.2.5 PTCA Balloons Catheters Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Interventional Cardiology Market, United States, Average Price ($), 2015-2025
3.4 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Interventional Cardiology Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Terumo Corp
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Cook Medical Inc
4.5.1 Company Overview
4.6 Asahi Kasei Corp
4.6.1 Company Overview
4.7 Philips Healthcare
4.7.1 Company Overview
4.8 Cardinal Health Inc
4.8.1 Company Overview

5 Interventional Cardiology Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.1.1 BTG Acquires Roxwood Medical
6.1.2 Royal Philips Acquires Spectranetics
6.2 Debt Offerings
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
6.3 Equity Offerings
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants
6.3.2 Osprey Medical Raises USD8.2 Million in Rights Offering of CDIs
6.3.3 Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares
6.3.4 Corindus Vascular Robotics Plans to Raise up to USD81.7 Million in Secondary Offering of Shares
6.3.5 AngioDynamics Prices Public Offering of Shares for USD38 Million
6.4 Partnerships
6.4.1 Corindus Vascular Robotics Enters into Partnership with BLOXR
6.5 Venture Financing
6.5.1 Cardiva Medical Raises Additional USD11 Million in Venture Financing
6.5.2 Shockwave Medical Raises Additional USD35 Million in Series C Financing
6.5.3 Saphena Medical Raises USD2.7 Million in Venture Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
7.1.2 Feb 27, 2018: Z-Medica Announces Appointment Of Eric Compton As CEO
7.1.3 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer
7.1.4 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
7.1.5 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
7.1.6 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer
7.1.7 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer
7.1.8 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer
7.1.9 Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer
7.1.10 Jan 03, 2018: Tryton Medical Announces New CEO and President
7.1.11 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
7.1.12 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President - Research & Development
7.1.13 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency
7.1.14 Oct 31, 2017: Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay
7.1.15 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer
7.1.16 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
7.1.17 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors
7.1.18 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen
7.1.19 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant
7.1.20 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors
7.1.21 Jul 31, 2017: Atara Biotherapeutics Announces Two Presentations at MSParis2017, Including Updated, Interim Results from a Phase 1 Study of Autologous ATA188 in Patients with Progressive Multiple Sclerosis
7.1.22 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
7.1.23 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer
7.1.24 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board
7.1.25 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board
7.1.26 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
7.1.27 May 26, 2017: Merit Medical Announces Appointment of New Director
7.1.28 Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team
7.2 Financial Announcements
7.2.1 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results
7.2.2 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
7.2.3 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
7.2.4 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
7.2.5 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results
7.2.6 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
7.2.7 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
7.2.8 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results
7.2.9 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
7.2.10 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
7.2.11 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology
7.2.12 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
7.2.13 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
7.2.14 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year
7.2.15 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
7.2.16 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting
7.2.17 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
7.2.18 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results
7.2.19 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results
7.2.20 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results
7.2.21 Oct 31, 2017: Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems
7.2.22 Oct 31, 2017: Northwell expands technology that precisely targets breast tumors
7.2.23 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results
7.2.24 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%
7.2.25 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
7.2.26 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results
7.2.27 Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results
7.2.28 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017
7.2.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results
7.2.30 Aug 15, 2017: CareRay Exhibits At FIME 2017
7.2.31 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results
7.2.32 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
7.2.33 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
7.2.34 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results
7.2.35 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results
7.2.36 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
7.2.37 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
7.2.38 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
7.2.39 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results
7.2.40 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
7.2.41 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
7.2.42 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
7.2.43 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results
7.2.44 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results
7.2.45 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results
7.2.46 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year
7.2.47 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results
7.2.48 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results
7.2.49 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
7.2.50 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance
7.2.51 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
7.2.52 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
7.2.53 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
7.2.54 Apr 20, 2017: bioMerieux: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE Marked
7.2.55 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model
7.2.56 Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors
7.3 Government and Public Interest
7.3.1 Jul 19, 2017: NIDEK’s Me1200 won the Ponts d’Or award in France
7.4 Legal And Regulatory
7.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital
7.4.2 Nov 03, 2017: Neovasc Provides Litigation Update
7.4.3 Oct 18, 2017: Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset
7.4.4 Sep 07, 2017: Ignyta To Host Conference Call And Live Webcast On September 11 To Provide Pipeline Review, Including Lead Candidate Entrectinib
7.5 Other Significant Developments
7.5.1 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
7.5.2 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017
7.5.3 Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma
7.5.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7.5.5 Apr 25, 2017: AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide
7.6 Product News
7.6.1 Jan 02, 2018: Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities
7.6.2 Oct 10, 2017: Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
7.7 Strategy And Business Planning
7.7.1 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Interventional Cardiology Market, United States, Volume (Units), 2015-2020
Table 14: Interventional Cardiology Market, United States, Volume (Units), 2021-2025
Table 15: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2020
Table 16: Arteriotomy Closure Devices Market, United States, Volume (Units), 2021-2025
Table 17: Cardiac Catheters Market, United States, Volume (Units), 2015-2020
Table 18: Cardiac Catheters Market, United States, Volume (Units), 2021-2025
Table 19: Coronary Stents Market, United States, Volume (Units), 2015-2020
Table 20: Coronary Stents Market, United States, Volume (Units), 2021-2025
Table 21: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2020
Table 22: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2021-2025
Table 23: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2020
Table 24: PTCA Balloons Catheters Market, United States, Volume (Units), 2021-2025
Table 25: Interventional Cardiology Market, United States, Average Price ($), 2015-2020
Table 26: Interventional Cardiology Market, United States, Average Price ($), 2021-2025
Table 27: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 28: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 29: Interventional Cardiology Market Pipeline Products
Table 30: BTG Acquires Roxwood Medical
Table 31: Royal Philips Acquires Spectranetics
Table 32: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
Table 33: Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants
Table 34: Osprey Medical Raises USD8.2 Million in Rights Offering of CDIs
Table 35: Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares
Table 36: Corindus Vascular Robotics Plans to Raise up to USD81.7 Million in Secondary Offering of Shares
Table 37: AngioDynamics Prices Public Offering of Shares for USD38 Million
Table 38: Corindus Vascular Robotics Enters into Partnership with BLOXR
Table 39: Cardiva Medical Raises Additional USD11 Million in Venture Financing
Table 40: Shockwave Medical Raises Additional USD35 Million in Series C Financing
Table 41: Saphena Medical Raises USD2.7 Million in Venture Financing
Table 42: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures
Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 7: Interventional Cardiology Market, United States, Volume (Units), 2015-2025
Figure 8: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2025
Figure 9: Cardiac Catheters Market, United States, Volume (Units), 2015-2025
Figure 10: Coronary Stents Market, United States, Volume (Units), 2015-2025
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2025
Figure 12: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2025
Figure 13: Interventional Cardiology Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Terumo Corp
  • Boston Scientific Corp
  • Medtronic Plc
  • Cook Medical Inc
  • Asahi Kasei Corp
  • Philips Healthcare
  • Cardinal Health Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll